Table 3.
Plasma metabolomic features predicted by chemical exposures in cross-validated PLS models.
| Biocrates | NMR | ||||
|---|---|---|---|---|---|
|
| |||||
| Metabolomic Features as Described by the Platforma | Corresponding HMDB Common Name(s)b | Corresponding HMDB ID(s)b | Metabolomic Features as Described by the Platforma | Corresponding HMDB Common Name(s)b | Corresponding HMDB ID(s)b |
| Propionylcarnitine | Propionylcarnitine | HMDB0000824 | Albumin | ||
| Methylglutarylcarnitine | 3-Methylglutarylcarnitine | HMDB0000552 | Cholesterol | ||
| O-methylglutarylcarnitine | Lipids | ||||
| Aspartic Acid | L-Aspartic acid | HMDB0000191 | Cholate | Cholic acid | HMDB0000619 |
| D-Aspartic acid | HMDB0006483 | Aspartate | L-Aspartic acid | HMDB0000191 | |
| Glutamic Acid | L-Glutamic acid | HMDB0000148 | Asparagine | L-Asparagine | HMDB0000168 |
| D-Glutamic acid | HMDB0003339 | Glutathione | Glutathione | HMDB0000125 | |
| Glycine | Glycine | HMDB0000123 | N,N-Dimethylglycine | Dimethylglycine | HMDB0000092 |
| Phenylalanine | L-Phenylalanine | HMDB0000159 | Trimethylamine | Trimethylamine | HMDB0000906 |
| D-phenylalanine | Fructose | D-Fructose | HMDB0000660 | ||
| Serotonin | Serotonin | HMDB0000259 | Glycerol | Glycerol | HMDB0000131 |
| Lysophosphatidylcholine a C18:1 | LysoPC(18:1(9Z)) | HMDB0002815 | Ascorbate | Ascorbic acid | HMDB0000044 |
| LysoPC(18:1(11Z)) | HMDB0010385 | Choline | Choline | HMDB0000097 | |
| 2-Oleoylglycerophosphocholine | HMDB0061701 | Creatinine | Creatinine | HMDB0000562 | |
| Lysophosphatidylcholine 18:1 | myo-Inositol | myo-Inositol | HMDB0000211 | ||
| 1-elaidoyl-sn-glycero-3-phosphocholine | Glyceryl of lipids | ||||
| Oleoyl-sn-glycero-3-phosphocholine | Overlapped | ||||
| Sum of Aromatic Amino Acids | L-Phenylalanine | HMDB0000159 | Tyrosine | L-Tyrosine | HMDB0000158 |
| D-phenylalanine | Histidine | L-Histidine | HMDB0000177 | ||
| L-Tryptophan | HMDB0000929 | p-Methylhistidine | 1-Methylhistidine | HMDB0000001 | |
| D-Tryptophan | HMDB0013609 | Phenylalanine | L-Phenylalanine | HMDB0000159 | |
| L-Tyrosine | HMDB0000158 | Tryptophan | L-Tryptophan | HMDB0000929 | |
| D-tyrosine | t-Methylhistidine | 3-Methylhistidine | HMDB0000479 | ||
| Methionine Oxidation | Methionine sulfoxide | HMDB0002005 | |||
| L-methionine (S)-S-oxide | |||||
| L-methionine (R)-S-oxide | |||||
| D-methionine S-oxide | |||||
| L-Methionine | HMDB0000696 | ||||
| D-methionine | |||||
| Serotonin Synthesis | L-Tryptophan | HMDB0000929 | |||
| D-Tryptophan | HMDB0013609 | ||||
| Serotonin | HMDB0000259 | ||||
Metabolomic features as described by the Biocrates AbsoluteIDQ® p180 kit or NMR bin annotations (via Chenomx NMR Suite 8.6 Professional); the values in this column correspond to variables in our analysis which were predicted by the chemical exposures.
HMDB Common Names and HMDB IDs corresponding to the metabolomic features as described by the two platforms; the manufacturers of the platforms provide materials to link the metabolomic features as described by the respective platforms to corresponding HMDB Common Names and HDMB IDs, the latter of which were used in pathway analyses.